The increasing level of frustration that Tom Gallo saw in cancer care prompted him to choose burnout as the theme for his year as president of the Association of Community Cancer Centers (ACCC).
The increasing level of frustration that Tom Gallo saw in cancer care prompted him to choose burnout as the theme for his year as president of the Association of Community Cancer Centers (ACCC).
Transcript
How did you settle on clinician burnout as your theme for your upcoming term as president of the Association of Community Cancer Centers?
I’ve been on the administrative side of cancer care for a long time. I’m not a clinician, and I’ve always told the clinicians that you could never pay me enough to do what they do—it’s an extremely difficult specialty, and I understand that and realize it.
But what I’ve seen in the past years is I’ve been involved, obviously, in groups like ACCC, and I’ve had the opportunity to travel and meet with lots of other both providers and administrators in cancer care, and I’ve seen an increasing level of frustration even anger at the bureaucracy and the system and how it’s taking away from their ability to provide good quality, efficient cancer care. There are so many physicians now that I go to talk to and they are pulling out from their pockets their smartphones with their countdown calculators, and the countdown is how many days, minutes, and hours until retirement.
Based on these changes that I’ve seen in the past few years, I thought it was time to try to address this and see if we could work together to find some solutions to get everyone focused on the patient and providing the best quality care to the patient.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Exploring Possibilities in Disease Modification in MPNs
October 25th 2024Experts are asking whether the study and treatment of myeloproliferative neoplasms (MPNs) is ready for a new era with new end points, with data that show how survival benefits are biologically linked to changes in the spleen, reduction in fibrosis, or other responses.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Prediagnosis Diet Improves Survival in Black Women With Deadly Ovarian Cancer
October 24th 2024Moderate prediagnosis adherence to dietary guidelines was associated with improved survival rates among Black women with high-grade serous ovarian cancer, the most common and lethal type of ovarian cancer.
Read More